NCT04152330

Brief Summary

Problem: With the increased survival rate of children with congenital heart disease, other health problems, in addition to the clinic, have emerged, such as the risks of developmental delay to which these children are exposed. There is a need for low-cost intervention studies that seek to minimize these risks. Objective: To evaluate the effect of an early stimulation program using parents as vectors of intervention, on the neurodevelopment of children with CHD Methodology: Randomized clinical trial, conducted with 44 dyads of parents-babies with CH considered as medium and high risk for developmental delays according to the guidelines of the American Heart Association (2012). The study will consist of two groups G1 (Intervention) and G2 (controls). G1 parents will receive guidance for 6 weeks of stimulation activities and will be instructed to keep an online execution diary, direct with the researcher through videos, and messages via cell phone. G2 parents will receive the standard guidelines currently used in pediatric cardiology clinics. Children from both groups will be assessed at the beginning and end of the 6 weeks by the Bayley Baby and Toddler Development Scales (3rd Edition). A questionnaire on the applicability of the protocol will be administered to the parents of the intervention group Expected results: Better neuropsychomotor performance in children after applying the early stimulation protocol. Perspectives: Create a body of information that can serve as a basis for the formulation of policies for intervention and surveillance of the development of this population.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 25, 2019

Completed
4 months until next milestone

First Posted

Study publicly available on registry

November 5, 2019

Completed
25 days until next milestone

Study Start

First participant enrolled

November 30, 2019

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2020

Completed
Last Updated

June 23, 2023

Status Verified

July 1, 2020

Enrollment Period

9 months

First QC Date

June 25, 2019

Last Update Submit

June 21, 2023

Conditions

Keywords

Congenital heart diseaseChildren developmentalParents training

Outcome Measures

Primary Outcomes (1)

  • Difference between groups

    Early intervention prevents developmental delays in children with congenital heart disease.

    6 moths

Study Arms (1)

Comparison between intervention and control group

OTHER

The subjects will be randomized to two groups, intervention group (IG) and control group (CG). Each day GI Parents-Baby receives guidance for 6 weeks of stimulation activities and will be instructed to keep an online execution diary, directly with the researcher of videos and messages via cell phone. "Parents" is understood as a generalist nomenclature and will be considered a parent, mother or principal. GC subjects receive standard guidance from the pediatric and pediatric cardiology clinic.

Other: Early stimulation protocol on neuropsychomotor development of children with congenital heart disease

Interventions

A parenting guidance booklet will be prepared. It will contain a specific program of stimulation activities for each stage of development in simple language and with illustrations. Subdivided into 4 areas: Cognition, Language, Large Motor and Fine Motor. The duration will be 6 weeks. Parents will participate in 1 individual face-to-face meeting, where they will receive information and clarification on the application of the booklet and will have a mobile communication channel to answer questions throughout the process. Parents will be instructed on the capabilities and limitations of their babies according to the child's congenital heart disease, as well as what is expected within the typical development for this age group and the importance of early stimulation activities in each child in 4 areas of development.

Comparison between intervention and control group

Eligibility Criteria

Age3 Months - 9 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • For babies
  • Diagnosis of congenital heart disease up to 3 months old.
  • Stable clinical condition (with medical clearance to receive the intervention), For parents
  • Parents are literate
  • Acceptance of the Responsible to participate in the research.
  • Have a mobile device capable of sending and receiving messages and videos.

You may not qualify if:

  • For babies
  • Suspected or diagnosed genetic syndrome;
  • Musculoskeletal or neurological malformation associated
  • inability to establish a primary caregiver as in the case of baby under state supervision.
  • for parents
  • Illiteracy
  • Presence of deafness, blindness or physical disability, when another family member cannot be responsible for the application of the protocol.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Instituto de cardiologia de porto alegre

Porto Alegre, Rio Grande do Sul, 90040-001, Brazil

Location

MeSH Terms

Conditions

Heart Defects, Congenital

Condition Hierarchy (Ancestors)

Cardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Fernanda Lucchese, Doutora

    Instituto de cardiologia de porto alegre

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 25, 2019

First Posted

November 5, 2019

Study Start

November 30, 2019

Primary Completion

August 30, 2020

Study Completion

August 30, 2020

Last Updated

June 23, 2023

Record last verified: 2020-07

Data Sharing

IPD Sharing
Will not share

Locations